Skip to main content
ILSUNG IS CO., LTD. logo

ILSUNG IS CO., LTD. — Investor Relations & Filings

Ticker · 003120 ISIN · KR7003120003 KO Manufacturing
Open in API
Filings indexed 212 across all filing types
Latest filing 2019-03-08 Director's Dealing
Country KR South Korea
Listing KO 003120

About ILSUNG IS CO., LTD.

https://www.ilsung.com/

ILSUNG IS CO., LTD. is a pharmaceutical company specializing in the development and manufacturing of therapeutic products. The company's core portfolio is focused on antibiotics, cardiovascular agents, anesthetics, and contrast media. It is actively expanding its research and development into new therapeutic areas, including treatments for gastrointestinal (GI), central nervous system (CNS), and other cardiovascular (CV) conditions.

Recent filings

Filing Released Lang Actions
최대주주등소유주식변동신고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) for Il-Sung Pharmaceutical. It details specific transactions (sales) by company executives and major shareholders, including the name of the individual (Yoon Deok-geun), the date of the transaction, and the change in share count. This falls under the category of Director's Dealing (DIRS) as it reports personal share transactions by company insiders/directors.
2019-03-08 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of an upcoming Annual General Meeting (AGM) for Il-Sung Pharmaceuticals. It details the date, location, and the specific agenda items (proposals) to be voted on by shareholders, such as financial statement approval, director appointments, and articles of incorporation changes. This document serves as the official proxy solicitation and meeting notice provided to shareholders prior to the event, which falls under the Proxy Solicitation & Information Statement category.
2019-03-07 Korean
주주총회집중일개최사유신고
Regulatory Filings Classification · 95% confidence The document is a short regulatory filing (under 5,000 characters) from Il-Sung Pharmaceutical notifying the market of the reason for holding their Annual General Meeting on a 'concentrated date' (a common regulatory requirement in South Korea). It does not contain the full meeting materials or proxy statements, but rather serves as a specific regulatory disclosure regarding meeting logistics. As it is a formal regulatory notification that does not fit into specific categories like AGM-R or PSI, it is classified as a Regulatory Filing (RNS).
2019-03-07 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is an official announcement from Il-Sung Pharmaceutical regarding the decision to pay cash dividends. It specifies the dividend amount per share, the total dividend amount, the dividend record date, and the date of the board resolution. This fits the definition of a 'Notice of Dividend Amount' (DIV).
2019-03-07 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for Il-Sung Pharmaceutical Co., Ltd. It contains the agenda for the 59th Annual General Meeting, including items such as financial statement approval, director appointments, and remuneration limits. It also includes detailed management information, business overviews, and financial statements (balance sheet, income statement, etc.) as required for shareholder review prior to the meeting. This document is a classic Proxy Solicitation & Information Statement, as it provides shareholders with the necessary information to vote on matters at the upcoming meeting.
2019-03-07 Korean
최대주주등소유주식변동신고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) for Il-Sung Pharmaceuticals. It details specific share transactions (sales) by an executive/major shareholder (Yoon Deok-geun) and provides a summary of total shareholdings for all major shareholders. This falls under the category of 'Director's Dealing' (DIRS) as it reports personal share transactions by company directors and executives.
2019-03-05 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.